Juanjuan Tang
Xuzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Efficacy and safety of gemcitabine/nab-paclitaxel combined with anlotinib and PD-1 inhibitors as a first-line treatment for advanced pancreatic cancer.
Journal: International immunopharmacology
Published: June 12, 2024
The relationship between the tertiary lymphoid structure and immune-infiltrating cells in gastrointestinal cancers: A systematic review and meta-analysis.
Journal: Immunity, inflammation and disease
Published: August 23, 2023
Safety and Efficacy of TACE + Lenvatinib in Treating Advanced Hepatocellular Carcinoma: A Systematic Review and Meta- analysis.
Journal: Journal of gastrointestinal and liver diseases : JGLD
Published: November 17, 2022
Knockdown of replication protein A 3 induces protective autophagy and enhances cisplatin sensitivity in lung adenocarcinoma by inhibiting AKT/mTOR signaling via binding to cyclin-dependent kinases regulatory subunit 2.
Journal: Drug development research
Published: December 09, 2021
Origin recognition complex 1 regulates phospholipase Cδ1 to inhibit cell proliferation, migration and epithelial-mesenchymal transition in lung adenocarcinoma.
Journal: Oncology letters
Published: December 01, 2021
p53 upregulates PLCε-IP3-Ca2+ pathway and inhibits autophagy through its target gene Rap2B.
Journal: Oncotarget
Published: March 22, 2017
p53-mediated autophagic regulation: A prospective strategy for cancer therapy.
Journal: Cancer letters
Published: January 22, 2015
p53 target gene Rap2B regulates the cytoskeleton and inhibits cell spreading.
Journal: Journal of cancer research and clinical oncology
Published: December 12, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026